Authors : Amida Nchaw; Francisca Mukete; Joseph Kobi

Volume/Issue : Volume 11 - 2026, Issue 5 - May

Google Scholar : https://tinyurl.com/3cmadu62

Scribd : https://tinyurl.com/2f2vnhvk

DOI : https://doi.org/10.38124/ijisrt/26May048

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Background: Uterine fibroids (leiomyomas) are the most common benign gynecologic tumors in women of reproductive age with disproportionately high rates in Black women who have an estimated cumulative lifetime rate of 80–90% by the age of 50. The lower levels of cutaneous synthesis are associated with deep melanin pigmentation with socioeconomic and environmental factors which makes black women highly vulnerable to vitamin D deficiency. New mechanistic and epidemiological studies identify vitamin D as a controller of cellular proliferation, extracellular matrix remodeling, and hormone-controlled signaling in uterine tissue.  Data Collection Methods: A retrospective cohort study was carried out, which assessed the relationship between serum vitamin D levels, and prevalence and severity of uterine fibroids in 312 women of reproductive age (25 to 45 years old) that were visiting three urban gynecology clinics between January 2018 and December 2024. The levels of serum 25-hydroxyvitamin D [25(OH)D] were compared in 186 ultrasound or MRI-proven women with uterine fibroids and 126 age-matched controls. The statistical tests and adjusted on confounders in the study included independent t-tests, chi-square tests, logistic regression, Pearson correlation, and multiple regression.

Keywords : Uterine Fibroids | Vitamin D Deficiency | Black Women | Leiomyoma | Racial Disparities | Prevention | Clinical Management

References :

1. Baird, D. D., Hill, M. C., Schectman, J. M., & Hollis, B. W. (2013). Vitamin D and the risk of uterine fibroids. Epidemiology, 24(3), 447–453. https://doi.org/10.1097/EDE.0b013e31828acca0
2. Paffoni, A., Somigliana, E., Vigano, P., Benaglia, L., Cardellicchio, L., Pagliardini, L., Papaleo, E., Candiani, M., & Fedele, L. (2013). Vitamin D status in women with uterine leiomyomas. Journal of Clinical Endocrinology and Metabolism, 98(8), E1374–E1378. https://doi.org/10.1210/jc.2013-1321
3. Bulun, S. E. (2013). Uterine fibroids. New England Journal of Medicine, 369(14), 1344–1355. https://doi.org/10.1056/NEJMra1209993
4. Rosen, C. J. (2011). Clinical practice: Vitamin D insufficiency. New England Journal of Medicine, 364(3), 248–254. https://doi.org/10.1056/NEJMcp1009570
5. Schlaff, W. D., Ackerman, R. T., Al-Hendy, A., Archer, D. F., Barnhart, K. T., Bradley, L. D., Carr, B. R., Feinberg, E. C., Hurtado, S. M., Kim, J. J., Liu, R. H., Mao, G., Owens, C. D., Poindexter, A. N., Puscheck, E. E., Rodriguez-Ginorio, H., Soper, J. T., Yao, Z., Carr, B. R., & Muneyyirci-Delale, O. (2020). Elagolix for heavy menstrual bleeding in women with uterine fibroids. New England Journal of Medicine, 382(4), 328–340. https://doi.org/10.1056/NEJMoa1904351
6. Al-Hendy, A., Badr, M., & Chuang, T. D. (2014). Anti-fibrotic effects of vitamin D analogue on human uterine fibroid cells and a murine model of uterine fibroid. Journal of the Society for Gynecologic Investigation, 21(4), 241–250. https://doi.org/10.1177/1933719113518991
7. Ciebiera, M., Włodarczyk, M., Zgliczyński, S., & Słabuszewska-Jóźwiak, A. (2018). The role of vitamin D in uterine fibroid biology, epidemiology, and treatment. Reproductive Sciences, 25(12), 1666–1676. https://doi.org/10.1177/1933719118767753
8. Halder, S. K., Goodwin, J. S., & Al-Hendy, A. (2011). 1,25-Dihydroxyvitamin D3 reduces TGF-β3-induced fibrosis-related gene expression in human uterine leiomyoma cells. Journal of Clinical Endocrinology and Metabolism, 96(4), E754–E762. https://doi.org/10.1210/jc.2010-1818
9. Pavone, D., Clemenza, S., Sorbi, F., Fambrini, M., & Petraglia, F. (2018). Epidemiology and risk factors of uterine fibroids. Best Practice and Research: Clinical Obstetrics and Gynaecology, 46, 3–11. https://doi.org/10.1016/j.bpobgyn.2017.09.004
10. Harris, S. S. (2006). Vitamin D and African Americans. Journal of Nutrition, 136(4), 1126–1129. https://doi.org/10.1093/jn/136.4.1126
11. Brakta, S., Diamond, J. S., Al-Hendy, A., Diamond, M. P., & Halder, S. K. (2015). Role of vitamin D in uterine fibroid biology. Fertility and Sterility, 104(3), 698–706. https://doi.org/10.1016/j.fertnstert.2015.05.031
12. Holick, M. F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281. https://doi.org/10.1056/NEJMra070553
13. Harmon, Q. E., Patchel, S. A., Denslow, S., Helpers, A., & Baird, D. D. (2016). Vitamin D and fibroid growth, incidence, and loss: A prospective study. Fertility and Sterility, 106(3), 737–744. https://doi.org/10.1016/j.fertnstert.2016.05.019
14. Borahay, M. A., Asoglu, M. R., Mas, A., Adam, S., Kilic, G. S., & Al-Hendy, A. (2015). Estrogen receptors and signaling in fibroids: Role in pathobiology and therapeutic implications. Reproductive Sciences, 22(9), 1075–1083. https://doi.org/10.1177/1933719114549554
15. Laughlin, S. K., Schroeder, J. C., & Baird, D. D. (2010). New directions in the epidemiology of uterine fibroids. Seminars in Reproductive Medicine, 28(3), 204–217. https://doi.org/10.1055/s-0030-1251477
16. Wallis, C. J. D., Bhatt, D. L., & Raman, J. D. (2020). Health disparities in cancer care. Journal of the American Medical Association Oncology, 6(10), 1511–1513. https://doi.org/10.1001/jamaoncol.2020.0781
17. Sabry, M., Halder, S. K., Allah, A. S., Roshdy, E., Rajaratnam, V., & Al-Hendy, A. (2013). Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: A cross-sectional observational study. International Journal of Women's Health, 5, 93–100. https://doi.org/10.2147/IJWH.S38800
18. Yockey, L. J., & Iwasaki, A. (2018). Interferons and proinflammatory cytokines in pregnancy and fetal development. Immunity, 49(3), 397–412. https://doi.org/10.1016/j.immuni.2018.07.017
19. Rajesh, H., Siow, J. K., & Chan, G. S. P. (2019). The molecular biology of uterine leiomyoma: Emerging concepts and their therapeutic implications. Journal of Gynecology and Obstetrics, 146(3), 284–293. https://doi.org/10.1002/jgo3.12174
20. Forrest, K. Y. Z., & Stuhldreher, W. L. (2011). Prevalence and correlates of vitamin D deficiency in US adults. Nutrition Research, 31(1), 48–54. https://doi.org/10.1016/j.nutres.2010.12.001
21. Lee, J. E., Hankinson, S. E., & Cho, E. (2008). Reproductive factors and risk of renal cell cancer: The Nurses' Health Study. American Journal of Epidemiology, 167(11), 1318–1324. https://doi.org/10.1093/aje/kwn041
22. Myers, E. R., Barber, M. D., Couchman, G. M., Dufour, D. R., Goddard, B. M., Grant, T. M., Hanstede, M. M., Holloway, D., & Viswanathan, M. (2002). Management of uterine fibroids. Evidence Report/Technology Assessment, 34, 1–136. PMID: 11812536
23. Bikle, D. D. (2014). Vitamin D metabolism, mechanism of action, and clinical applications. Chemistry & Biology, 21(3), 319–329. https://doi.org/10.1016/j.chembiol.2013.12.016
24. Laughlin-Tommaso, S. K. (2018). Alternatives to hysterectomy: Management of uterine fibroids. Obstetrics and Gynecology Clinics, 45(3), 397–413. https://doi.org/10.1016/j.ogc.2018.04.002
25. Donnez, J., & Dolmans, M. M. (2016). Uterine fibroid management: From the present to the future. Human Reproduction Update, 22(6), 665–686. https://doi.org/10.1093/humupd/dmw023
26. Ness, R. B., & Cottreau, C. (1999). Possible role of ovarian epithelial inflammation in ovarian cancer. Journal of the National Cancer Institute, 91(17), 1459–1467. https://doi.org/10.1093/jnci/91.17.1459
27. Sharan, C., Halder, S. K., Thota, C., Jaleel, T., Nair, S., & Al-Hendy, A. (2011). Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertility and Sterility, 95(1), 247–253. https://doi.org/10.1016/j.fertnstert.2010.07.1041
28. Pérez-López, F. R., Pasupuleti, V., Mezones-Holguin, E., Benites-Zapata, V. A., Thota, P., Deshpande, A., & Hernandez, A. V. (2015). Effect of vitamin D supplementation on arterial blood pressure: A systematic review and meta-analysis of 46 randomized controlled trials. Atherosclerosis, 236(1), 1–14. https://doi.org/10.1016/j.atherosclerosis.2014.10.020
29. Hansdottir, S., Monick, M. M., Hinde, S. L., Lovan, N., Look, D. C., & Hunninghake, G. W. (2008). Respiratory epithelial cells convert inactive vitamin D to its active form: Potential effects on host defense. Journal of Immunology, 181(10), 7090–7099. https://doi.org/10.4049/jimmunol.181.10.7090
30. Chiaffarino, F., Parazzini, F., La Vecchia, C., Chatenoud, L., Di Cintio, E., & Marsico, S. (1999). Diet and uterine myomas. Obstetrics and Gynecology, 94(3), 395–398. https://doi.org/10.1016/S0029-7844(99)00305-1
31. Stewart, E. A., Cookson, C. L., Gandolfo, R. A., & Schulze-Rath, R. (2017). Epidemiology of uterine fibroids: A systematic review. BJOG: An International Journal of Obstetrics and Gynaecology, 124(10), 1501–1512. https://doi.org/10.1111/1471-0528.14640
32. Halder, S. K., Sharan, C., Al-Hendy, O., & Al-Hendy, A. (2012). Paricalcitol, a vitamin D receptor activator, inhibits tumor formation in a murine model of uterine fibroids. Reproductive Sciences, 19(12), 1316–1328. https://doi.org/10.1177/1933719112450325
33. Yin, P., Lin, Z., Cheng, Y. H., Marsh, E. E., Utsunomiya, H., Ishikawa, H., Xue, Q., Kim, J. J., Kurita, T., Bulun, S. E., & Reierstad, S. (2007). Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. Journal of Clinical Endocrinology and Metabolism, 92(11), 4459–4466. https://doi.org/10.1210/jc.2007-0494
34. Eltoukhi, H. M., Modi, M. N., Weston, M., Armstrong, A. Y., & Stewart, E. A. (2014). The health disparities of uterine fibroid tumors for African American women: A public health issue. American Journal of Obstetrics and Gynecology, 210(3), 194–199. https://doi.org/10.1016/j.ajog.2013.08.008
35. Freedman, D. M., Looker, A. C., Chang, S. C., & Graubard, B. I. (2007). Prospective study of serum vitamin D and cancer mortality in the United States. Journal of the National Cancer Institute, 99(21), 1594–1602. https://doi.org/10.1093/jnci/djm204
36. Cesen-Cummings, K., Copland, J. A., Barrett, J. C., Walker, C. L., & Davis, B. J. (2000). Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling. Journal of the Society for Gynecologic Investigation, 7(1), 3–9. https://doi.org/10.1177/107155760000700101
37. Wise, L. A., Palmer, J. R., Harlow, B. L., Spiegelman, D., Stewart, E. A., Adams-Campbell, L. L., & Rosenberg, L. (2004). Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: A prospective study. American Journal of Epidemiology, 159(2), 113–123. https://doi.org/10.1093/aje/kwh016
38. Segars, J. H., Parrott, E. C., Nagel, J. D., Guo, X. C., Gao, X., Birnbaum, L. S., Pinn, V. W., & Dixon, D. (2014). Proceedings from the third National Institutes of Health International Congress on advances in uterine leiomyoma research: Comprehensive review, conference summary and future recommendations. Human Reproduction Update, 20(3), 309–333. https://doi.org/10.1093/humupd/dmt058
39. Marshall, L. M., Spiegelman, D., Barbieri, R. L., Goldman, M. B., Manson, J. E., Colditz, G. A., Willett, W. C., & Hunter, D. J. (1997). Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstetrics and Gynecology, 90(6), 967–973. https://doi.org/10.1016/S0029-7844(97)00534-6